DA
CNMD icon

Duality Advisers’s CONMED CNMD Stock Holding History

Duality Advisers’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,541
Closed -$1.48M – 115
2024
Q1 		$1.48M Buy
18,541
+11,110
+150% +$990K 0.15% 242
2023
Q4 		$814K Buy
7,431
+109
+1% +$11.3K 0.09% 347
2023
Q3 		$738K Buy
+7,322
New +$841K 0.09% 354
2022
Q4 		– Sell
-6,544
Closed -$525K – 617
2022
Q3 		$525K Sell
6,544
-17,067
-72% -$1.61M 0.06% 412
2022
Q2 		$2.26M Buy
+23,611
New +$2.83M 0.22% 174

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Duality Advisers's CNMD Position: Q2 2024 in Review

Duality Advisers sold out of CONMED (CNMD) in Q2 2024, closing a stake of 18,541 shares — an estimated $1.48M sold.

Duality Advisers first reported a position in CNMD in Q2 2022 and held it in 5 quarters. The position peaked at $2.26M in Q2 2022. 290 funds tracked by Wall St. Rank hold CNMD as of Q2 2024.

  • Duality Advisers reported no remaining CONMED position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 18,541 CONMED shares in Q2 2024, an estimated $1.48M.
  • Duality Advisers first reported a position in CONMED in Q2 2022 and held it in 5 quarters.
  • Duality Advisers's CONMED position peaked at $2.26M in Q2 2022.
  • 290 funds tracked by Wall St. Rank held CONMED as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.